NCT06923046Recruiting
Implementation of Team Clinic for Type 2 Diabetes (TCT2)
Implementation of Team Clinic for Type 2 Diabetes (TCT2): A Randomized Standard Care-controlled Two-site 80-subject Clinical Trial of Shared Medical Appointment Model for Adolescents With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 29 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to learn if shared medical appointment is an acceptable way to deliver care to youth with type 2 diabetes. The main question\[s\] it aims to answer are: * Is shared medical appointments an acceptable care delivery model for this population? * Does shared medical appointment improve psychosocial outcomes for this population? Participants will attend quarterly clinic appointments and group activities and take surveys. Researchers will compare this intervention to standard of care.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 25 Mar 2025
- Start date
- Aug 2025
- Primary completion date
- May 2027
- Lead sponsor
- Children's Hospital Los Angeles
- Diseases
- Type 2 diabetes
- NCT number
- NCT06923046
What you commit to
- Study type: Interventional
- Planned participants: 160
- From Aug 2025 to the primary completion date, May 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants who are non-verbal or unable to participate in group activities and discussions
- Pregnancy
- Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent
- Caregiver/Parents Participants
- -Inability or unwillingness of individual to give written informed consent
Who the study is looking for
- Receives care for type 2 diabetes at either CHLA or UCSF
- English speaking youth
- Youth prescribed medication for type 2 diabetes
- English or Spanish speaking caregivers
- Age 12 to 18 years old at the time of enrollment
- Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys
- Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant.
- Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session
- Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys.
Criteria the registry did not label
- Patient/AYA Participants
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital Los Angeles Coordinator of this site? Confirm its status | Los Angeles | United States | Recruiting |
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.